![]() |
市場調查報告書
商品編碼
1913367
感染控制用品市場:市場機會、成長促進因素、產業趨勢分析及預測(2026-2035 年)Infection Control Supplies Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
全球感染控制用品市場預計到 2025 年將達到 564 億美元,到 2035 年將達到 1,061 億美元,年複合成長率為 6.8%。

市場成長得益於醫療環境中感染疾病率的上升、對預防通訊協定的日益重視以及防護和消毒技術的不斷創新。全球醫療系統日益重視降低感染風險,以改善患者預後並降低治療成本。長期健康問題的日益增多增加了患者與醫療機構的接觸,提高了感染風險,並進一步強化了對強力的感染預防措施的需求。免疫功能低下的患者需要加強保護,這進一步推動了對先進感染控制解決方案的需求。全球重症監護和外科手術能力的提升也促進了現代消毒和滅菌技術的廣泛應用。隨著醫療機構更加重視安全、效率和合規性,感染控制用品已成為臨床運作的重要組成部分,從而支持了醫院、診所和門診機構市場的持續成長。
| 市場覆蓋範圍 | |
|---|---|
| 開始年份 | 2025 |
| 預測期 | 2026-2035 |
| 初始市場規模 | 564億美元 |
| 市場規模預測 | 1061億美元 |
| 複合年成長率 | 6.8% |
預計到2025年,消毒劑品類將創造154億美元的收入,佔市場佔有率的27.2%。由於人們對衛生標準的認知不斷提高以及合規要求日益嚴格,醫療機構對消毒劑的需求仍然強勁。法律規範和以衛生為中心的政策也進一步推動了醫療機構對消毒劑的採用。
2025年,批發分銷管道的價值將達到257億美元。這些仲介業者在確保獲得必要的感染控制產品方面發揮著至關重要的作用。它們的規模、定價柔軟性和物流能力使它們成為需要確保穩定供應的大規模醫療機構的首選採購管道。
預計到2024年,北美感染控制用品市佔率將達到42.5%。該地區的領先地位得益於其完善的醫療基礎設施、高度的感染預防意識以及嚴格的監管執行。醫療程序的不斷增加和機構合規要求的嚴格性也持續支撐全部區域穩定的需求。
The Global Infection Control Supplies Market was valued at USD 56.4 billion in 2025 and is estimated to grow at a CAGR of 6.8% to reach USD 106.1 billion by 2035.

Market growth is supported by the rising incidence of infectious conditions within healthcare environments, increased emphasis on prevention protocols, and continuous innovation in protective and disinfection technologies. Healthcare systems worldwide are placing greater priority on minimizing infection risks to improve patient outcomes and reduce treatment costs. The growing burden of long-term health conditions has intensified interactions with healthcare facilities, increasing exposure risks and reinforcing the need for robust infection prevention measures. Patients with compromised immunity require heightened protection, further driving demand for advanced infection control solutions. Expansion of critical care and surgical capacity globally has also contributed to higher utilization of modern disinfection and sterilization technologies. As healthcare providers focus on safety, efficiency, and regulatory compliance, infection control supplies have become a fundamental component of clinical operations, supporting sustained market expansion across hospitals, clinics, and outpatient care settings.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $56.4 Billion |
| Forecast Value | $106.1 Billion |
| CAGR | 6.8% |
The disinfectants category generated USD 15.4 billion during 2025 and accounted for a 27.2% share. Strong demand continues across healthcare environments due to heightened awareness of sanitation standards and strict compliance requirements. Regulatory oversight and hygiene-focused policies continue to reinforce adoption across medical facilities.
The wholesalers distribution channel reached USD 25.7 billion in 2025. These intermediaries play a critical role in ensuring reliable access to essential infection control products. Their scale, pricing flexibility, and logistical capabilities make them a preferred sourcing option for large healthcare organizations that require consistent supply availability.
North America Infection Control Supplies Market represented 42.5% share in 2024. Regional dominance is supported by a well-developed healthcare infrastructure, high awareness of infection prevention, and strict regulatory enforcement. Rising procedural volumes and strong institutional compliance requirements continue to support stable demand across the region.
Key companies active in the Global Infection Control Supplies Market include Ecolab, 3M, Steris, Getinge, Cardinal Health, Kimberly-Clark Corporation, Henry Schein, Reckitt, Advanced Sterilization Products, Belimed Deutschland GmbH, Steelco, Cantel Medical, Matachana Group, Dentsply Sirona, and Envista Holdings Corporation. Companies operating in the Global Infection Control Supplies Market are strengthening their market position through innovation, portfolio expansion, and strategic partnerships. Manufacturers are investing in advanced product development to improve effectiveness, safety, and ease of use. Expansion of automated and digital-enabled solutions is enhancing efficiency and compliance for healthcare providers. Strategic collaborations with hospitals and distributors help secure long-term supply contracts.